FrancoisJGeoffroyMD

PubMed

• 117 citations
  Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...
  Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim, Fabio M Iwamoto, David D Tran, George Ansstas, Charles S Cobbs, Jason A Heth, Michael E S...> ;JAMA Oncology. 2023 Jan 1
• 9 citations
  Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (...
  Linda M. Liau, Keyoumars Ashkan, David Tran, Jian Campian, John E. Trusheim, Charles S. Cobbs, Jason Heth, Michael Salacz, Sarah A. Taylor, Stacy D. D’Andre, Fabio M. ...> ;Journal of Translational Medicine. 2018 Jun 29
• 167 citations
  First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
  Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Charles S Cobbs, Jason A Heth, Michael Salacz, Sarah Taylor, Stacy D D'Andre, Fabio M Iw...> ;Journal of Translational Medicine. 2018 May 29
• 8 citations
  Isolated CNS Hodgkin's lymphoma: implications for tissue diagnosis
  Derek L. Martinez, Meena Gujrati, Francois Geoffroy, Andrew J. Tsung> ;CNS Oncology. 2014 Dec 2
• 62 citations
  A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Ce...
  Lisa A. Kottschade, Vera J. Suman, Domingo G. Perez, Robert R. McWilliams, Judith S. Kaur, Thomas Amatruda, Francois J. Geoffroy, Howard M. Gross, Peter A. Cohen, Anth...> ;Cancer. 2013 Feb 1
• 162 citations
  Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
  Bret Edward Buckley Friday, S. Keith Anderson, Jan C. Buckner, Chunrong Yu, Caterina Giannini, Francois J. Geoffroy, John Schwerkoske, Miroslaw Mazurczak, Howard Gross...> ;Neuro-Oncology. 2012 Feb 1
• A randomized phase II trial of temozolomide (TMZ) and bevacizumab (BEV) or nab-paclitaxel (nab-P)/carboplatin (CBDCA) and bevacizumab (BEV) in patients with unresectab...
  Kottschade LA, Suman V, Perez DG, McWilliams RR, Kaur JS, Amatruda T, Geoffroy FJ, Gross HM, Cohen PA, Jaslowski AJ, Kosel ML, Markovic S> ;J. Clin. Oncol.. 2011-05-20
• 206 citations
  Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group...
  Paul D. Brown, Sunil Krishnan, J. N. Sarkaria, Wenting Wu, Kurt A. Jaeckle, Joon H. Uhm, Francois J. Geoffroy, Robert M. Arusell, Gaspar J. Kitange, Robert B. Jenkins,...> ;Journal of Clinical Oncology. 2008 Dec 1
• 67 citations
  Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
  Sunil Krishnan, Paul D. Brown, Karla V. Ballman, John B. Fiveash, Joon H. Uhm, Caterina Giannini, Kurt A. Jaeckle, Francois J. Geoffroy, L. Burt Nabors, Jan C. Buckner> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Jul 15
• 5 citations
  Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
  Grace K. Dy, James R. Jett, Francois J. Geoffroy, Keith D. Krewer, Henry D. Tazelaar, Matthew J. Maurer, Kendrith M. Rowland, James A. Mailliard, James E. Krook, Shake...> ;Journal of Thoracic Oncology. 2006 Mar 1
• Phase I trial of erlotinib with radiation therapy (RT) in patients with glioblastoma multiforme (GBM).
  Krishnan S, Brown P, Ballman K, Fiveash J, Uhm J, Giannini C, Geoffroy F, Nabors L, Buckner J> ;J. Clin. Oncol.. 2005-06-01
• 115 citations
  Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
  Steven E. Schild, James A. Bonner, Thomas G. Shanahan, Burke J. Brooks, Randolph S. Marks, Susan Geyer, Shauna L. Hillman, Gist H. Farr, Henry D. Tazelaar, James E. Kr...> ;International Journal of Radiation Oncology, Biology, Physics. 2004 Jul 15
• 9 citations
  Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
  Edith A. Perez, Francois J. Geoffroy, Shauna Hillman, Elizabeth Johnson, Gist H. Farr, Henry D Tazelarr, Alan K. Hatfield, James E. Krook, James A. Maillard, Ralph Lev...> ;Lung Cancer. 2004 Jun 1
• 41 citations
  Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells.
  Jean L. Grem, Diana Nguyen, Brian P. Monahan, Vivian Kao, F. Geoffroy> ;Biochemical Pharmacology. 1999 Aug 1
• 14 citations
  Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification.
  James D. Siebert, Debra A. Mulvaney, Kari L. Potter, Paul A. S. Fishkin, Francois J. Geoffroy> ;American Journal of Clinical Pathology. 1999 Mar 1
• 14 citations
  Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
  Q. F. Ren, C.J. van Groeningen, A. Hardcastle, G. W. Aherne, F. Geoffroy, Carmen J. Allegra, P.G. Johnston, Jean L. Grem> ;Oncology Research. 1997 Jan 1
• 2 citations
  Effects of 9-Aminocamptothecin on Newly Synthesized DNA in Patient Bone Marrow Samples
  F. Geoffroy, William Dahut, Chris H. Takimoto, Jean L. Grem> ;Clinical Cancer Research. 1995 Nov 1
• 15 citations
  Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
  Jean L. Grem, F. Geoffroy, Pedro M. Politi, D. P. Cuddy, Douglas D. Ross, Diana Nguyen, Seth M. Steinberg, Carmen J. Allegra> ;Molecular Pharmacology. 1995 Aug 1
• 11 citations
  Determinants of trimetrexate lethality in human colon cancer cells
  Jean L. Grem, Donna Voeller, F. Geoffroy, E. Horak, Patrick G. Johnston, Carmen J. Allegra> ;British Journal of Cancer. 1994 Dec 1
• 1 citations
  Cytotoxicity and metabolism of 4-methoxy-8-(β-d-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cells
  Jean L. Grem, Pamela Daychild, James C. Drake, F. Geoffroy, Jane B. Trepel, Farzaneh Pirnia, Carmen J. Allegra> ;Biochemical Pharmacology. 1994 Nov 29
• 4 citations
  Chemotherapy of advanced gastrointestinal cancer
  F. Geoffroy, Jean L. Grem> ;Current Opinion in Oncology. 1994 Jul 1
• 37 citations
  Enhanced cytotoxicity with interleukin-1α and 5-fluorouracil in HCT116 colon cancer cells
  F. Geoffroy, Carmen J. Allegra, Birandra K. Sinha, Jean L. Grem> ;Oncology Research. 1994 Jan 1
• A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.
  George, C. M., Vogelzang, N. J., Rini, B. I., Geoffroy, F. J., Kollipara, P., Stadler, W. M.> ;Ann Oncol. 2002 Jan
• Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
  Ismail, A., Van Groeningen, C. J., Hardcastle, A., Ren, Q., Aherne, G. W., Geoffroy, F., Allegra, C. J., Grem, J. L.> ;Mol Pharmacol. 1998 Feb
• High affinity human antibodies by phage display.
  Aujame, L., Geoffroy, F., Sodoyer, R.> ;Hum Antibodies. 1997
• Join now to see all